-
<![CDATA[Optimizing Care in Unresectable Stage III NSCLC: Chemoradiation and Immunotherapy]]>
28 Oct 2025 18:12 GMT
… stage III lung cancer benefit from concurrent chemoradiation followed by … adding immunotherapy during concurrent chemoradiation does not improve outcomes … after rather than during chemoradiation. Patients who are completely … of definitive chemoradiation.
-
<![CDATA[From Mutation to Medicine: Targeted Therapies in Lung Cancer]]>
18 Oct 2025 21:25 GMT
… 1% to 4% of lung cancers, most often in … Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer … receptor non-small cell lung cancer (FLAURA2) (FLAURA2). Clinicaltrials … Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, …
-
Prognostic Impact of Advanced Lung Cancer Inflammation Index (ALI) on Immunotherapy Outcomes in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Post Hoc Analysis
08 Oct 2025 06:55 GMT
… systemic inflammation. The Advanced Lung Cancer Inflammation Index (ALI) … beyond an era of chemoradiation? Int J Cancer. … and advanced lung cancer inflammation index (ALI). Transl Lung Cancer Res. 2019 … mature neutrophils in lung cancer tissues impairs the …
-
<![CDATA[Twice-Daily Radiation Boosts Quality of Life in Small Cell Lung Cancer]]>
01 Oct 2025 16:05 GMT
… in limited-stage small cell lung cancer, directly reflecting patients’ experiences.
… randomly assigned to receive standard chemoradiation (platinum/etoposide every … Of Chemoradiation (Crt) +/- Atezolizumab In Limited-Stage Small Cell Lung Cancer …
-
Patient-reported outcome analysis of NRG Oncology trial in limited-stage small cell lung cancer suggests quality of life benefit with twice - (vs once -) daily radiation
01 Oct 2025 01:17 GMT
… concurrent chemoradiation for limited-state small cell lung cancer was … patients receiving standard chemoradiation with thoracic RT … after completion of chemoradiation. Higher completion correlated … on both arms during chemoradiation as expected; however …
-
Patient-Reported Outcomes from NRG Oncology Trial Indicate Quality of Life Improvement with Twice-Daily vs. Once-Daily Radiation in Limited-Stage Small Cell Lung Cancer
01 Oct 2025 00:00 GMT
… disease.
Small cell lung cancer, especially in its … stage small cell lung cancer patients. These … Keywords: Small cell lung cancer, limited-stage, chemoradiation, atezolizumab, immunotherapy … Oncology
Tags: aggressive lung cancer managementASTRO Annual Meeting …
-
Pulsed Low-Dose-Rate Chemoradiation Therapy Reduces Side Effects Without Compromising Efficacy in Esophageal and Non-Small Cell Lung Cancer Patients
30 Sep 2025 21:39 GMT
… lung cancers. This approach, termed pulsed low dose rate (PLDR) chemoradiation … esophageal and select lung cancer patient populations.
… Non-small cell lung cancer, Chemoradiation, Pulsed low dose … esophagitisnon-small cell lung cancer therapypulsed low-dose …
-
<![CDATA[Poll Results Spotlight Key Lung Cancer Abstracts Driving Anticipation Ahead of ESMO 2025]]>
27 Sep 2025 02:12 GMT
… late-breaking abstracts in lung cancer expected to shape … to identify which lung cancer abstracts and topics … Small Cell Lung Cancer (NSCLC) After Platinum-Based Concurrent Chemoradiation (cCRT … stage iii non-small cell lung cancer (NSCLC) (SKYSCRAPER-03 …
-
Innovative Roswell Park Radiation Therapy Protocol in Lung Cancer to Be Highlighted at ASTRO Annual Meeting
25 Sep 2025 01:20 GMT
… radiation therapy to treat lung cancer at the American … with non-small cell lung cancer (NSCLC). The study … -Operative Non-Small Cell Lung Cancer”
Science Highlights Session: Sunday … and Neck Cancer Receiving Definitive Chemoradiation” (Abstract 2704), to …
-
Libtayo® (cemiplimab) Plus Chemotherapy Results at Five Years Reinforce Significant and Durable Improvements in Survival Outcomes for Advanced Non-small Cell Lung Cancer
09 Sep 2025 11:00 GMT
… 2025 World Conference on Lung Cancer (WCLC) hosted by … not eligible for definitive chemoradiation, and 7% had pretreated … a type of lung cancer called non-small cell lung cancer (NSCLC).
… metastatic non-small cell lung cancer; uncertainty of the utilization …
About
© 1995-2025